drug

gepirone

1 story · latest Sep 22, 2026

Status: FDA approved Sep 2023 · NDA021164
Brand: Exxua

Relationships

Developed by Aytu Biopharma, Inc

Timeline

Aytu reports first full launch quarter for EXXUA, fiscal 2026 results

Sep 22Quarterly updateAytu Biopharma, Inc gepirone

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.